Sep 22, 2026 10 0
Uploaded by Hazel
Favorite
Share
More Options
11
Immune-related adverse events and neutrophil-to-lymphocyte ratio as prognostic indicators in gynecologic cancer patients receiving pembrolizumab - a real-world analysis_Page 1

Open in WPS to view all 11 pages